Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Xpovio
Pharma
Karyopharm hits FDA setback with Xpovio's cancer expansion bid
The company now plans to conduct another study in a subgroup of patients with topline data expected about two years from now.
Angus Liu
Mar 2, 2022 11:03am
Karyopharm plans FDA filing for Xpovio in endometrial cancer
Feb 9, 2022 8:46am
Karyopharm snags DLBCL nod for Xpovio
Jun 23, 2020 10:40am
Karyopharm's controversial Xpovio could see wider market
Mar 10, 2020 11:58am
Karyopharm's Xpovio nabs FDA nod despite checkered past
Jul 8, 2019 9:22am
